FDA says bee pollen weight loss products pose health risks

FDA: bee pollen weight loss products pose health risks
Some contain undeclared ingredients that can harm people with high blood pressure, other ailments, agency says.

(HealthDay)—Some bee pollen products marketed for weight loss may actually threaten your health, the U.S. Food and Drug Administration warns.

These potentially dangerous products have been found to contain undeclared ingredients that may harm people who have conditions such as , irregular heartbeat and bipolar disorder, the agency said.

According to the FDA, the undeclared ingredients sibutramine and/or phenolphthalein have been found in the following bee pollen products: Zi Xiu Tang, Ultimate Formula, Fat Zero, Bella Vi Amp'd Up, Insane Amp'd Up, Slim Trim U, Infinity, Perfect Body Solution, Asset Extreme, Asset Extreme Plus, Asset Bold, and Asset Bee Pollen.

Sibutramine was removed from the U.S. market in late 2010 after studies showed that it increased people's risk of heart attack and stroke. Phenolphthalein, a laxative and a suspected cancer-causing agent, isn't approved in the United States, the FDA said.

The agency said it has received more than 50 reports of problems caused by tainted bee pollen weight loss products, including at least one death, serious heart issues, chest pain, heart palpitations, increased heart rate, elevated blood pressure, seizures, suicidal thoughts, anxiety, insomnia and diarrhea.

The FDA is testing other bee pollen weight loss products suspected to contain undeclared drugs.

The FDA also noted that many bee pollen products make unproven claims about treating or preventing a number of diseases and signs or symptoms of disease, including obesity, allergies, high blood pressure and cholesterol.

"When people buy these tainted bee pollen weight loss products, they are unknowingly taking one or more hidden drugs that have been banned from the market," Gary Coody, FDA's national health fraud coordinator, said in an agency news release.

Consumers and health care professionals should report any adverse events caused by bee pollen products to the FDA's MedWatch program at http://www..gov/Safety/MedWatch.

"It is tempting to believe that a quick and effortless weight loss supplement is safe for use," Jason Humbert, a senior regulatory manager with FDA's Office of Regulatory Affairs, said in the news release. "But given the fact that these products contain a hidden dangerous ingredient, consumers should avoid taking them."

More information: The U.S. National Institute of Diabetes and Digestive and Kidney Diseases explains how to choose a safe and successful weight loss program.

add to favorites email to friend print save as pdf

Related Stories

Bee pollen supplements can cause anaphylactic reactions

May 22, 2012

Although many people take bee pollen as a health supplement, it can cause severe anaphylactic reactions. However, most people are unaware of the risks, states an article published in CMAJ (Canadian Medical Association Journal). ...

FDA approves generic version of celebrex

Jun 03, 2014

(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval to the first generic version of the pain reliever Celebrex (celecoxib).

Recommended for you

Ebola vaccine not before late 2016: GSK researcher

Oct 17, 2014

An Ebola vaccine by British pharmaceuticals giant GlaxoSmithKline may not be ready for commercial use until late 2016 and should therefore not be seen as the "primary answer" to the current outbreak, a company researcher ...

Chimerix gets FDA OK to test drug for Ebola

Oct 17, 2014

(AP)—A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Esbriet, ofev approved to treat deadly lung disease

Oct 16, 2014

(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).

FDA weighs removing bolded warning from Chantix

Oct 14, 2014

(AP)—The Food and Drug Administration will ask a panel of experts later this week whether a bold-letter warning on the anti-smoking drug Chantix should be removed based on company-supported evidence that the drug does not ...

Drug-coated balloon catheter approved

Oct 13, 2014

(HealthDay)—The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been approved by the U.S. Food and Drug Administration.

User comments